MedPath

Communicating Risk Information for Obesity

Not Applicable
Completed
Conditions
Obesity
Interventions
Behavioral: Lifestyle
Genetic: Genetic
Registration Number
NCT01355224
Lead Sponsor
Boston University
Brief Summary

This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized Medicine Collaborative (CPMC), see below for description of CPMC.

Detailed Description

The investigators will conduct a randomized controlled feasibility trial to examine the short-term impact of personalized risk feedback for obesity. This study is uniquely situated to provide important data on how individuals interpret various sources of risk information and how they arrive at an overall perception of risk for a condition. Taken altogether, study findings will be used to serve as an overall model for future intervention efforts to effectively communicate obesity risk information with the goal of improving weight management and overall population health.

CPMC-The CPMC is an ongoing evidence-based longitudinal research study designed to determine the utility of using personal genome information in health management and clinical decision-making. They collect saliva samples, perform genetic analysis and provide genetic risk feedback for several disease conditions including coronary artery disease and type 2 diabetes. The present study will build upon the existing genetic testing and web feedback infrastructure at Coriell to conduct behavioral science research to address critical public health questions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
798
Inclusion Criteria

Must be age 18 or older, active enrollees in the CPMC trial, and able to read and write in English.

Exclusion Criteria

Individuals that do not meet the inclusion criteria.

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Lifestyle risk feedbackLifestyleOnly personal lifestyle risk information provided
Both genetic or lifestyle risk feedbackGeneticPersonal genetic and lifestyle information provided
Genetic risk feedbackGeneticOnly personal genetic risk information provided
Both genetic or lifestyle risk feedbackLifestylePersonal genetic and lifestyle information provided
Primary Outcome Measures
NameTimeMethod
Intentions to Lose Weight - Effect of Study Arm on Outcomes3 months after viewing obesity risk assessment

Intention to lose 10lbs in the next 6 months was measured on a 5-point likert scale (1-strongly disagree;5-strongly agree). Responses were examined by study arm.

Intention to Lose Weight - Impact of Risk Status3 months after viewing obesity risk assessment

Intention to lose 10lbs in the next 6 months measured on a 5-point likert scale (1-strongly disagree;5-strongly agree). This was examined by study arm and level of feedback received (high or elevated risk vs low or non-elevated risk).

Intention to Lose Weight - Combined Risk3 months from viewing obesity risk assessment

Intention to lose 10lbs in the next 6 months on a 5-point likert scale (1-strongly disagree; 5-strongly agree). This was examined by study arm and by combined levels of feedback (e.g. elevated genetic risk and non-elevated lifestyle risk)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Coriell Institute for Medical Research

🇺🇸

Camden, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath